Aptorum Group Ltd (APM) Stock: A Look at the Monthly Trend

The stock of Aptorum Group Ltd (APM) has gone down by -44.55% for the week, with a -58.92% drop in the past month and a -78.55% drop in the past quarter. The volatility ratio for the week is 20.42%, and the volatility levels for the past 30 days are 10.39% for APM. The simple moving average for the past 20 days is -50.94% for APM’s stock, with a -82.32% simple moving average for the past 200 days.

Is It Worth Investing in Aptorum Group Ltd (NASDAQ: APM) Right Now?

Additionally, the 36-month beta value for APM is 1.26. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for APM is 2.17M and currently, short sellers hold a 0.21% ratio of that float. The average trading volume of APM on November 18, 2024 was 20.41K shares.

APM) stock’s latest price update

The stock of Aptorum Group Ltd (NASDAQ: APM) has decreased by -38.00 when compared to last closing price of 1.10.Despite this, the company has seen a loss of -44.55% in its stock price over the last five trading days. businesswire.com reported 2024-04-30 that NEW YORK & LONDON–(BUSINESS WIRE)–Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group” or “We”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced financial results for the fiscal year ended December 31, 2023, and provided an update on corporate developments. Mr. Ian Huen, Chief Executive Officer and Executive Director of Aptorum Group, commented, “Throughout 2023, we have maintained a.

APM Trading at -62.17% from the 50-Day Moving Average

After a stumble in the market that brought APM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -96.10% of loss for the given period.

Volatility was left at 10.39%, however, over the last 30 days, the volatility rate increased by 20.42%, as shares sank -60.12% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -77.42% lower at present.

During the last 5 trading sessions, APM fell by -44.55%, which changed the moving average for the period of 200-days by -59.40% in comparison to the 20-day moving average, which settled at $1.3902. In addition, Aptorum Group Ltd saw -72.15% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for APM

Current profitability levels for the company are sitting at:

  • -24.41 for the present operating margin
  • -2.6 for the gross margin

The net margin for Aptorum Group Ltd stands at -6.55. The total capital return value is set at -0.57. Equity return is now at value -13.93, with -13.61 for asset returns.

Based on Aptorum Group Ltd (APM), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -2.54. The debt to equity ratio resting at 0.12. The interest coverage ratio of the stock is -86.91.

Currently, EBITDA for the company is -9.6 million with net debt to EBITDA at -0.41. When we switch over and look at the enterprise to sales, we see a ratio of 11.15. The receivables turnover for the company is 6.08for trailing twelve months and the total asset turnover is 0.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.18.

Conclusion

In conclusion, Aptorum Group Ltd (APM) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts